心臓安全性サービス市場 : 2028年までの世界予測

Report Overview

The global cardiac safety services market is projected to reach USD 1,282 million by 2028 from USD 739 million in 2023, at a CAGR of 11.6% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the rising incidence of cardiovascular diseases, increasing research and development activities, and increasing outsourcing of cardiac safety services. For instance, The active pharmaceutical drug pipeline is increasing annually, primarily led by an increase in research activities. Pharmaceutical companies are increasingly outsourcing research activities to academic organizations and Contract Research Organizations (CROs) to stay competitive and retain focus on core functions. The R&D tasks primarily outsourced range from basic research to late-stage development, genetic engineering, target validation, assay development, hit exploration & lead optimization (hit candidates-as-a-service), safety studies/tests in animal models, and clinical trials involving humans. The growing pipeline of pharmaceutical companies is a key reason attributing to the high outsourcing of services.

“The pharmaceutical and biopharmaceutical companies segment accounted for the largest share by end user during the forecast period”
In 2022, pharmaceutical & biopharmaceutical companies segment accounted for the largest share by end user in the global cardiac safety services market. Cardiac safety services are utilized by pharmaceutical and biopharmaceutical companies to oversee clinical trials for newly developed drugs, with these companies dedicated to the development of innovative treatments for diverse medical conditions and diseases. These companies are required to provide precise data pertaining to drug development and subsequently complete applications for submission to regulatory authorities. Cardiac safety concerns frequently lead to the discontinuation of potentially promising drugs during their development, creating a substantial demand for cardiac safety services within the pharmaceutical and biopharmaceutical companies.

“Europe: The second largest region in the cardiac safety services market”
Europe accounted for the second-largest market for cardiac safety services market after North America. The European cardiac safety services market has witnessed significant growth in recent years, driven by demographic changes, such as the growing incidence of chronic diseases. This is attributed to the rising geriatric population in the region. As per the European Commission, by 2025, more than 20% of Europeans are expected to be 65 years and above, with a rapid increase in the number of people aged 80 years and above, indicating strong demand growth for healthcare services. This will drive pharmaceutical and biopharmaceutical clinical trial activity for novel drug discoveries and directly contribute to the growth of associated markets, such as cardiac safety services.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: C-level – 50%, D-level – 20%, and Others – 30%
• By Region: North America -35%, Europe -24%, Asia-Pacific -25%, Latin America – 10%, Middle East – 4% & Africa- 2%

List of Companies Profiled in the Report:
• Laboratory Corporation of America Holdings (US)
• Medpace (US)
• Koninklijke Philips N.V. (Netherland)
• Clario (US)
• Ncardia (Netherlands)
• IQVIA (US)
• Certara (US)
• PPD Inc. (Part of Thermo Fisher Scientific, Inc.) (US)
• SGS S.A. (Switzerland)
• ICON Plc (Ireland)
• WuXi AppTec (China)
• Charles River Laboratories (US)
• Eurofins Scientific (Luxembourg)
• Frontage Labs (US)
• Banook Group (France)
• Biotrial (France)
• Celerion (US)
• Richmond Pharmacology (UK)
• PhysioStim (France)
• Shanghai Medicilon Inc. (China)
• ACM Global Laboratories (India)
• Worldwide Clinical Trials (US)
• Nova Research Laboratories LLC (US)
• Biobeat (Israel)
• CRS. Experts. Early Phase. (Germany)

Research Coverage:
This report provides a detailed picture of the cardiac safety services market. It aims at estimating the size and future growth potential of the market across different segments such as the type, service type, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges

The report provides insights on the following pointers:
• Analysis of key drivers (Rising incidence of cardiovascular diseases, Increasing outsourcing of cardiac safety services related activities, and Large number of clinical trials pertaining to the cardiac -related issues), restraints (Stringent regulations and compliance guidelines, The Iinadequacy of cardiotoxicity testing), opportunities (Emergence of new methods to curb cardiotoxicity, Growth in biosimilars and biologics), and challenges (High cost of cardiac safety evaluation services) influencing the growth of the market.
• Service Development/Innovation: Detailed insights on newly launched service platform and technological assessment of the cardiac safety services market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cardiac safety services market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Laboratory Corporation of America Holdings (US), Medpace (US), Koninklijke Philips N.V. (Netherland), Clario (US), Ncardia (Netherlands), IQVIA (US), Certara (US), PPD Inc. (Part of Thermo Fisher Scientific, Inc.) (US), SGS S.A. (Switzerland), ICON Plc (Ireland), WuXi AppTec (China), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), Frontage Labs (US), Banook Group (France), Biotrial (France), Celerion (US), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), ACM Global Laboratories (India), Worldwide Clinical Trials (US), Nova Research Laboratories LLC (US), Biobeat (Israel), and CRS. Experts. Early Phase. (Germany).

Table of Contents

1            INTRODUCTION            27

1.1         STUDY OBJECTIVES      27

1.2         MARKET DEFINITION   27

1.2.1      INCLUSIONS AND EXCLUSIONS 27

1.3         MARKET SCOPE             28

1.3.1      MARKETS COVERED     28

FIGURE 1           CARDIAC SAFETY SERVICES MARKET SEGMENTATION 28

1.3.2      YEARS CONSIDERED     28

1.4         CURRENCY CONSIDERED          29

1.5         LIMITATIONS   29

1.6         STAKEHOLDERS            29

1.6.1      RECESSION IMPACT      30

2            RESEARCH METHODOLOGY     31

2.1         RESEARCH DATA           31

FIGURE 2           RESEARCH DESIGN       31

2.1.1      SECONDARY DATA       32

2.1.2      PRIMARY DATA 33

FIGURE 3           CARDIAC SAFETY SERVICES MARKET: BREAKDOWN OF PRIMARIES        33

2.2         MARKET SIZE ESTIMATION       34

FIGURE 4           MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS     34

FIGURE 5           MARKET SIZE ESTIMATION FOR CARDIAC SAFETY SERVICES: REVENUE SHARE ANALYSIS       35

2.2.1      INSIGHTS FROM PRIMARIES      36

FIGURE 6           MARKET VALIDATION FROM PRIMARY EXPERTS           36

2.2.2      SEGMENTATION ASSESSMENT (BY TYPE, SERVICE TYPE, AND END USER)   36

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       36

2.3         GROWTH FORECAST    37

FIGURE 8           CARDIAC SAFETY SERVICES MARKET: CAGR PROJECTIONS              38

FIGURE 9           CARDIAC SAFETY SERVICES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    38

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    39

FIGURE 10         DATA TRIANGULATION METHODOLOGY         39

2.5         RESEARCH ASSUMPTIONS         40

2.6         RISK ANALYSIS 40

2.7         RECESSION IMPACT ANALYSIS 40

TABLE 1             GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)         40

3            EXECUTIVE SUMMARY 42

FIGURE 11         CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 42

FIGURE 12         CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION)             43

FIGURE 13         CARDIAC SAFETY SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)     43

FIGURE 14         GEOGRAPHICAL SNAPSHOT OF CARDIAC SAFETY SERVICES MARKET            44

4            PREMIUM INSIGHTS      45

4.1         CARDIAC SAFETY SERVICES MARKET OVERVIEW           45

FIGURE 15         RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD             45

4.2         NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE AND COUNTRY (2022)           46

FIGURE 16         INTEGRATED SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022           46

4.3         CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2023 VS. 2028              46

FIGURE 17         ECG/HOLTER MEASUREMENT SERVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD         46

4.4         CARDIAC SAFETY SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           47

FIGURE 18         EUROPEAN COUNTRIES TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD         47

5            MARKET OVERVIEW     48

5.1         INTRODUCTION            48

5.2         MARKET DYNAMICS     49

FIGURE 19         CARDIAC SAFETY SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 49

TABLE 2             CARDIAC SAFETY SERVICES MARKET: IMPACT ANALYSIS              50

5.2.1      DRIVERS            50

5.2.1.1   Rising incidence of cardiovascular diseases    50

5.2.1.2   Increasing outsourcing of services to CROs    51

5.2.1.3   High number of clinical trials for cardiac treatments    52

FIGURE 20         TOTAL CLINICAL TRIAL REGISTRATIONS WORLDWIDE (2000−2022)      52

5.2.2      RESTRAINTS     53

5.2.2.1   Stringent regulations and compliance guidelines          53

5.2.2.2   Inadequacy of cardiotoxicity testing 54

5.2.3      OPPORTUNITIES           54

5.2.3.1   Emergence of innovative testing methods      54

5.2.3.2   Growth in biosimilars and biologics development        55

5.2.4      CHALLENGES   56

5.2.4.1   High cost of cardiac safety evaluation services              56

5.2.5      TRENDS             56

5.2.5.1   Rising technological advancements  56

5.2.5.2   Transition to patient-centric approach           57

5.3         TECHNOLOGY ANALYSIS           58

5.4         VALUE CHAIN ANALYSIS            59

FIGURE 21         CARDIAC SAFETY SERVICES MARKET: VALUE CHAIN ANALYSIS              59

5.5         ECOSYSTEM ANALYSIS 60

FIGURE 22         CARDIAC SAFETY SERVICES MARKET: ECOSYSTEM ANALYSIS              60

5.6         PORTER’S FIVE FORCES ANALYSIS         60

TABLE 3             CARDIAC SAFETY SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS          60

5.6.1      INTENSITY OF COMPETITIVE RIVALRY 60

5.6.2      BARGAINING POWER OF SUPPLIERS     61

5.6.3      BARGAINING POWER OF BUYERS           61

5.6.4      THREAT OF SUBSTITUTES         61

5.6.5      THREAT OF NEW ENTRANTS    61

5.7         REGULATORY ANALYSIS            61

5.7.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          61

TABLE 4             NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         61

TABLE 5             EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         62

TABLE 6             ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         62

TABLE 7             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         63

TABLE 8             MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         63

5.8         PRICING ANALYSIS        64

5.9         KEY CONFERENCES AND EVENTS          65

TABLE 9             CARDIAC SAFETY SERVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2024)           65

5.10       KEY STAKEHOLDERS AND BUYING CRITERIA    66

5.10.1    KEY STAKEHOLDERS IN BUYING PROCESS         66

FIGURE 23         CARDIAC SAFETY SERVICES MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 66

5.10.2    BUYING CRITERIA         67

FIGURE 24         KEY BUYING CRITERIA FOR END USERS              67

6            CARDIAC SAFETY SERVICES MARKET, BY TYPE 68

6.1         INTRODUCTION            69

TABLE 10           CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          69

6.2         INTEGRATED SERVICES             69

6.2.1      COMPREHENSIVE DATA INTEGRATION AND IMPROVED QUALITY TO PROPEL MARKET          69

TABLE 11           INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)       70

TABLE 12           NORTH AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         70

TABLE 13           EUROPE: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            71

TABLE 14           ASIA PACIFIC: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         71

TABLE 15           LATIN AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         72

6.3         STANDALONE SERVICES            72

6.3.1      COST-EFFECTIVE BENEFITS TO SUPPORT MARKET GROWTH   72

TABLE 16           STANDALONE CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)       73

TABLE 17           NORTH AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         73

TABLE 18           EUROPE: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            74

TABLE 19           ASIA PACIFIC: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         74

TABLE 20           LATIN AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         75

7            CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE             76

7.1         INTRODUCTION            77

TABLE 21           CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)     77

7.2         ECG/HOLTER MEASUREMENT SERVICES           77

7.2.1      FEATURES SUCH AS TREND ASSESSMENT AND ENHANCED QUALITY METRICS TO BOOST DEMAND 77

TABLE 22           ECG/HOLTER MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)          78

TABLE 23           NORTH AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         78

TABLE 24           EUROPE: ECG/HOLTER MEASUREMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)    79

TABLE 25           ASIA PACIFIC: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         79

TABLE 26           LATIN AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         80

7.3         BLOOD PRESSURE MEASUREMENT SERVICES   80

7.3.1      GROWING IMPORTANCE IN CARDIOVASCULAR HEALTH ASSESSMENT TO SUPPORT GROWTH 80

TABLE 27           BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)       81

TABLE 28           NORTH AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET BY COUNTRY, 2021–2028 (USD MILLION)     81

TABLE 29           EUROPE: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         82

TABLE 30           ASIA PACIFIC: BLOOD PRESSURE MANAGEMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)    82

TABLE 31           LATIN AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         83

7.4         CARDIOVASCULAR IMAGING SERVICES 83

7.4.1      NEED TO ASSESS DRUG EFFICACY AND SAFETY TO PROPEL DEMAND              83

TABLE 32           CARDIOVASCULAR IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)          84

TABLE 33           NORTH AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         84

TABLE 34           EUROPE: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    85

TABLE 35          ASIA PACIFIC: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            85

TABLE 36           LATIN AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         86

7.5         THOROUGH QT STUDIES          86

7.5.1      NEED TO CONDUCT CLINICAL INVESTIGATIONS AND MEASURE MEDICAL INTERVENTION TO DRIVE GROWTH 86

TABLE 37           THOROUGH QT STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION) 87

TABLE 38           NORTH AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    87

TABLE 39           EUROPE: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          88

TABLE 40           ASIA PACIFIC: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    88

TABLE 41           LATIN AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    89

7.6         OTHER CARDIAC SAFETY SERVICES      89

TABLE 42           OTHER CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)          89

TABLE 43           NORTH AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         90

TABLE 44           EUROPE: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    90

TABLE 45           ASIA PACIFIC: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    91

TABLE 46           LATIN AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            91

8            CARDIAC SAFETY SERVICES MARKET, BY END USER      92

8.1         INTRODUCTION            93

TABLE 47           CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 93

8.2         PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES        93

8.2.1      GROWING COLLABORATIONS FOR CLINICAL TRIALS TO PROPEL MARKET            93

TABLE 48           CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)              94

TABLE 49           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          94

TABLE 50           EUROPE: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          95

TABLE 51           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          95

TABLE 52           LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          96

8.3         CONTRACT RESEARCH ORGANIZATIONS (CROS)           96

8.3.1      RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET            96

TABLE 53           CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2021–2028 (USD MILLION)              96

TABLE 54           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 97

TABLE 55           EUROPE: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 97

TABLE 56           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 98

TABLE 57           LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 98

9            CARDIAC SAFETY SERVICES MARKET, BY REGION          99

9.1         INTRODUCTION            100

TABLE 58           CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 100

9.2         NORTH AMERICA          100

FIGURE 25         NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET SNAPSHOT        101

TABLE 59           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    102

TABLE 60           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             102

TABLE 61           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          103

TABLE 62           NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    103

9.2.1      US         104

9.2.1.1   Increasing clinical trials for drug discovery & development to drive market              104

TABLE 63           TOTAL NUMBER OF CLINICAL TRIALS REGISTERED      104

TABLE 64           US: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105

TABLE 65           US: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          105

TABLE 66           US: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)     105

9.2.2      CANADA            106

9.2.2.1   Availability of high-end facilities for drug discovery to propel market       106

TABLE 67           CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     106

TABLE 68           CANADA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             107

TABLE 69           CANADA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          107

9.2.3      NORTH AMERICA: RECESSION IMPACT 108

9.3         EUROPE             108

FIGURE 26         EUROPE: CARDIAC SAFETY SERVICES MARKET SNAPSHOT              109

TABLE 70           EUROPE: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          110

TABLE 71           EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     110

TABLE 72           EUROPE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             111

TABLE 73           EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          111

9.3.1      GERMANY         111

9.3.1.1   High pharmaceutical production to propel market       111

TABLE 74           GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          112

TABLE 75           GERMANY: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             112

TABLE 76          GERMANY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          113

9.3.2      UK         113

9.3.2.1   Growth in life science research to drive market            113

TABLE 77           UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113

TABLE 78           UK: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          114

TABLE 79           UK: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)     114

9.3.3      FRANCE             114

9.3.3.1   Growing focus on biosimilars to fuel market   114

TABLE 80           FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     115

TABLE 81           FRANCE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             115

TABLE 82           FRANCE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          116

9.3.4      ITALY   116

9.3.4.1   Availability of funding for novel services to support market growth          116

TABLE 83           ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     116

TABLE 84          ITALY: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          117

TABLE 85           ITALY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          117

9.3.5      SPAIN   117

9.3.5.1   Presence of multinational pharma companies to drive market    117

TABLE 86           SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     118

TABLE 87          SPAIN: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          118

TABLE 88           SPAIN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          119

9.3.6      REST OF EUROPE           119

TABLE 89           REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             120

TABLE 90           REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          120

TABLE 91           REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    121

9.3.7      EUROPE: RECESSION IMPACT   121

9.4         ASIA PACIFIC    121

TABLE 92           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    122

TABLE 93           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          122

TABLE 94           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          123

TABLE 95           ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             123

9.4.1      CHINA  123

9.4.1.1   China to dominate APAC market for cardiac safety services       123

TABLE 96           CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     124

TABLE 97           CHINA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             124

TABLE 98           CHINA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          125

9.4.2      JAPAN  125

9.4.2.1   Supportive regulatory policies for safety measures to drive market           125

TABLE 99           JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     125

TABLE 100        JAPAN: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          126

TABLE 101         JAPAN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          126

9.4.3      INDIA   126

9.4.3.1   Rising growth in pharmaceutical & biotechnology industries to propel market              126

TABLE 102         INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     127

TABLE 103        INDIA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          127

TABLE 104         INDIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          128

9.4.4      AUSTRALIA       128

9.4.4.1   Rising investments by medical device companies to support market growth              128

TABLE 105         AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          128

TABLE 106         AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             129

TABLE 107         AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             129

9.4.5      REST OF ASIA PACIFIC  129

TABLE 108         REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       130

TABLE 109         REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)     130

TABLE 110         REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)            131

9.4.6      ASIA PACIFIC: RECESSION IMPACT        131

9.5         LATIN AMERICA             131

TABLE 111         LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    132

TABLE 112         LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             132

TABLE 113         LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          132

TABLE 114         LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             133

9.5.1      BRAZIL 133

9.5.1.1   Low costs and presence of skilled clinical investigators to drive market    133

TABLE 115         BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     133

TABLE 116         BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             134

TABLE 117         BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          134

9.5.2      REST OF LATIN AMERICA          134

TABLE 118         REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    135

TABLE 119         REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 135

TABLE 120         REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)         136

9.5.3      LATIN AMERICA: RECESSION IMPACT   136

9.6         MIDDLE EAST  136

9.6.1      GROWING CRO HUB TO DRIVE MARKET            136

TABLE 121         MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          137

TABLE 122         MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)          137

TABLE 123         MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             138

9.6.2      MIDDLE EAST: RECESSION IMPACT       138

9.7         AFRICA 139

9.7.1      RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH        139

TABLE 124         AFRICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     139

TABLE 125         AFRICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)             140

TABLE 126         AFRICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          140

9.7.2      AFRICA: RECESSION IMPACT     141

10          COMPETITIVE LANDSCAPE       142

10.1       INTRODUCTION            142

10.2       STRATEGIES ADOPTED BY KEY PLAYERS           143

FIGURE 27         CARDIAC SAFETY SERVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS (2020−2023)   143

10.3       MARKET SHARE ANALYSIS         144

FIGURE 28         CARDIAC SAFETY SERVICES MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)          144

TABLE 127         CARDIAC SAFETY SERVICES MARKET: INTENSITY OF COMPETITIVE RIVALRY             144

10.4       REVENUE SHARE ANALYSIS       145

FIGURE 29         REVENUE SHARE ANALYSIS FOR KEY COMPANIES (2020−2022)              145

10.5       COMPANY EVALUATION MATRIX FOR KEY PLAYERS     146

10.5.1    STARS  146

10.5.2    PERVASIVE PLAYERS     146

10.5.3    EMERGING LEADERS    146

10.5.4    PARTICIPANTS 147

FIGURE 30         CARDIAC SAFETY SERVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)          147

10.6       COMPETITIVE BENCHMARKING OF LEADING 25 PLAYERS (2022)              148

10.6.1    SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 148

TABLE 128         CARDIAC SAFETY SERVICES MARKET: SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS       148

10.6.2    REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)          149

TABLE 129         CARDIAC SAFETY SERVICES MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS       149

10.7       COMPANY EVALUATION MATRIX FOR STARTUPS/SMES             150

10.7.1    PROGRESSIVE COMPANIES       150

10.7.2    RESPONSIVE COMPANIES          150

10.7.3    DYNAMIC COMPANIES 150

10.7.4    STARTING BLOCKS       150

FIGURE 31         CARDIAC SAFETY SERVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)    151

10.8       COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS (2022)              152

TABLE 130         CARDIAC SAFETY SERVICES MARKET: DETAILED LIST OF STARTUPS/SME PLAYERS          152

TABLE 131         CARDIAC SAFETY SERVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS 153

10.9       COMPETITIVE SCENARIO AND TRENDS             153

10.9.1    SERVICE LAUNCHES     153

TABLE 132         CARDIAC SAFETY SERVICES MARKET: SERVICE LAUNCHES (JANUARY 2020−SEPTEMBER 2023)        153

10.9.2    DEALS  154

TABLE 133         CARDIAC SAFETY SERVICES MARKET: DEALS (JANUARY 2020−SEPTEMBER 2023)             154

10.9.3    OTHER DEVELOPMENTS           155

TABLE 134         CARDIAC SAFETY SERVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2020−SEPTEMBER 2023)    155

11          COMPANY PROFILES    157

11.1       KEY PLAYERS   157

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

11.1.1    LABORATORY CORPORATION OF AMERICA HOLDINGS             157

TABLE 135         LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW    157

FIGURE 32         LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)    158

11.1.2    MEDPACE         160

TABLE 136         MEDPACE: BUSINESS OVERVIEW           160

FIGURE 33         MEDPACE: COMPANY SNAPSHOT (2022)            160

11.1.3    KONINKLIJKE PHILIPS N.V.        163

TABLE 137         KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW          163

FIGURE 34         KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)              164

11.1.4    CLARIO 166

TABLE 138         CLARIO: BUSINESS OVERVIEW  166

11.1.5    NCARDIA           168

TABLE 139         NCARDIA: BUSINESS OVERVIEW             168

11.1.6    IQVIA   169

TABLE 140         IQVIA: BUSINESS OVERVIEW     169

FIGURE 35         IQVIA: COMPANY SNAPSHOT (2022)      170

11.1.7    CERTARA          171

TABLE 141         CERTARA: BUSINESS OVERVIEW            171

FIGURE 36         CERTARA: COMPANY SNAPSHOT (2022)             172

11.1.8    PPD, INC. (PART OF THERMO FISHER SCIENTIFIC, INC.)             173

TABLE 142         PPD, INC.: BUSINESS OVERVIEW             173

FIGURE 37         PPD, INC.: COMPANY SNAPSHOT (2022)             174

11.1.9    SGS S.A. 177

TABLE 143         SGS S.A.: BUSINESS OVERVIEW  177

FIGURE 38         SGS S.A.: COMPANY SNAPSHOT (2022)  178

11.1.10  ICON PLC          180

TABLE 144         ICON PLC: BUSINESS OVERVIEW            180

FIGURE 39         ICON PLC: COMPANY SNAPSHOT (2022)             180

11.1.11  WUXI APPTEC  182

TABLE 145         WUXI APPTEC: BUSINESS OVERVIEW    182

FIGURE 40         WUXI APPTEC: COMPANY SNAPSHOT (2022)     183

11.1.12  CHARLES RIVER LABORATORIES            184

TABLE 146         CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 184

FIGURE 41         CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT              185

11.1.13  EUROFINS SCIENTIFIC  186

TABLE 147         EUROFINS SCIENTIFIC: BUSINESS OVERVIEW    186

FIGURE 42         EUROFINS SCIENTIFIC: COMPANY SNAPSHOT  186

11.1.14  FRONTAGE LABS           188

TABLE 148         FRONTAGE LABS: BUSINESS OVERVIEW             188

FIGURE 43         FRONTAGE LABS: COMPANY SNAPSHOT (2022) 189

11.1.15  BANOOK GROUP           191

TABLE 149         BANOOK GROUP: BUSINESS OVERVIEW             191

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

11.2       OTHER PLAYERS           193

11.2.1    BIOTRIAL          193

11.2.2    CELERION         193

11.2.3    RICHMOND PHARMACOLOGY  194

11.2.4    PHYSIOSTIM     194

11.2.5    SHANGHAI MEDICILON INC.     195

11.2.6    ACM GLOBAL LABORATORIES  195

11.2.7    WORLDWIDE CLINICAL TRIALS 196

11.2.8    NOVA RESEARCH LABORATORIES LLC 196

11.2.9    BIOBEAT           197

11.2.10  CRS. EXPERTS. EARLY PHASE.   197

12          APPENDIX         198

12.1       DISCUSSION GUIDE      198

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             202

12.3       CUSTOMIZATION OPTIONS      204

12.4       RELATED REPORTS       204

12.5       AUTHOR DETAILS         205